US biscuit and cookie manufacturer D.F Stauffer has announced it is to close its facility in Cuba, New York.

The company, which has been producing Animal Crackers since 1871, said the decision was taken as part of an effort to optimise manufacturing operations and efficiencies.

The facility will close at the end of this year and manufacturing will then be centred on the firm’s two remaining ‘higher production’ plants in York, Pennsylvania, and Santa Ana, California.

Employees at the Cuba, NY, facility are being offered the chance to transfer to Stauffer’s other sites. 

A request from just-food for further information on the closure had not been answered at the time of writing.

Stauffer’s roots are in York, Pennsylavania, where the first Animal Crackers were produced. The company is now a subsidiary of Japan’s Meiji Co.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Its other products include Whales baked cheese crackers and a variety of cookies under the Stauffer’s brand, including Ginger Snaps, Lemon Snaps, Pumpkin Pie Snaps and Apple Pie Snaps.

In May Meiji booked a fall in net profit for the 12 months to the end of March, although the Japanese pharma-to-food group reported higher operating income and saw its sales inch upwards.